1. Home
  2. ETNB vs ROG Comparison

ETNB vs ROG Comparison

Compare ETNB & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • ROG
  • Stock Information
  • Founded
  • ETNB 2018
  • ROG 1832
  • Country
  • ETNB United States
  • ROG United States
  • Employees
  • ETNB N/A
  • ROG N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • ROG Industrial Machinery/Components
  • Sector
  • ETNB Health Care
  • ROG Technology
  • Exchange
  • ETNB Nasdaq
  • ROG Nasdaq
  • Market Cap
  • ETNB 1.5B
  • ROG 1.4B
  • IPO Year
  • ETNB 2019
  • ROG N/A
  • Fundamental
  • Price
  • ETNB $8.87
  • ROG $78.91
  • Analyst Decision
  • ETNB Strong Buy
  • ROG Strong Buy
  • Analyst Count
  • ETNB 10
  • ROG 2
  • Target Price
  • ETNB $27.22
  • ROG $85.00
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • ROG 233.1K
  • Earning Date
  • ETNB 11-06-2025
  • ROG 10-23-2025
  • Dividend Yield
  • ETNB N/A
  • ROG N/A
  • EPS Growth
  • ETNB N/A
  • ROG N/A
  • EPS
  • ETNB N/A
  • ROG N/A
  • Revenue
  • ETNB N/A
  • ROG $795,800,000.00
  • Revenue This Year
  • ETNB N/A
  • ROG N/A
  • Revenue Next Year
  • ETNB N/A
  • ROG $7.80
  • P/E Ratio
  • ETNB N/A
  • ROG N/A
  • Revenue Growth
  • ETNB N/A
  • ROG N/A
  • 52 Week Low
  • ETNB $4.16
  • ROG $51.43
  • 52 Week High
  • ETNB $11.84
  • ROG $114.05
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 43.45
  • ROG 60.07
  • Support Level
  • ETNB $8.46
  • ROG $76.30
  • Resistance Level
  • ETNB $9.47
  • ROG $80.52
  • Average True Range (ATR)
  • ETNB 0.46
  • ROG 2.41
  • MACD
  • ETNB -0.02
  • ROG -0.08
  • Stochastic Oscillator
  • ETNB 33.33
  • ROG 72.32

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

Share on Social Networks: